GDF Facts & Figures
- Years of existence: 8
- Total funds raised for GDF operations: $268 million
- Number of patient treatments supplied to date: 13,910,758
- Number of countries that have received first-line drug deliveries: 88
- Number of countries that have received second-line deliveries: 42
- Number of High Burden Countries that received drugs through a Grant or Direct Procurement Service: 17
- Number of countries that have received diagnostic kits deliveries: 17
- Number of countries receiving GDF drugs: 93
- Number of Technical assistance missions conducted: 334
- Duration of GDF grants: 3 years (renewable)
- Number of Global Fund recipients that have used GDF's services: 50
- Average cost to treat a patient infected with drug-sensitive TB: $22.40
- GDF's operational costs (as percentage of funding): 5
- Primary funders of GDF grants and DP drug orders: UNITAID and The Global Fund
Last updated: July 2009
Please email us at gdf@who.int for the most recent facts and figures.
In This Section
Latest GDF brochures


GDF is ISO 9001:2000 compliant for provision of quality-assured anti-TB drugs and related services to eligible national TB control programmes.